Nanomix Corporation
Nanomix Corporation develops and commercializes mobile point-of-care diagnostic system that is used in performing a range of in vitro diagnostic tests in various environments. Its products are designed to enhance healthcare delivery by bringing diagnostic information to the point of initial patient interaction, whether in the hospital or in settings, such as nursing facilities, elderly homes, urg… Read more
Nanomix Corporation (NNMX) - Net Assets
Latest net assets as of March 2023: $-13.83 Million USD
Based on the latest financial reports, Nanomix Corporation (NNMX) has net assets worth $-13.83 Million USD as of March 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($982.05K) and total liabilities ($14.81 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-13.83 Million |
| % of Total Assets | -1408.55% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | -493.96% |
| Growth Volatility | 392.13 |
Nanomix Corporation - Net Assets Trend (2010–2022)
This chart illustrates how Nanomix Corporation's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Nanomix Corporation (2010–2022)
The table below shows the annual net assets of Nanomix Corporation from 2010 to 2022.
| Year | Net Assets | Change |
|---|---|---|
| 2022-12-31 | $-13.18 Million | +39.18% |
| 2021-12-31 | $-21.67 Million | +58.80% |
| 2020-12-31 | $-52.60 Million | -585.53% |
| 2019-12-31 | $-7.67 Million | -85.06% |
| 2018-12-31 | $-4.15 Million | -6.76% |
| 2017-12-31 | $-3.88 Million | -24.52% |
| 2016-12-31 | $-3.12 Million | -487.86% |
| 2015-12-31 | $-530.54K | -810.58% |
| 2014-12-31 | $74.66K | -97.77% |
| 2013-12-31 | $3.35 Million | +380.32% |
| 2012-12-31 | $696.46K | +63.99% |
| 2011-12-31 | $424.69K | -20.45% |
| 2010-12-31 | $533.89K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Nanomix Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 11893384900.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2022)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $48.78K | % |
| Other Comprehensive Income | $238.00K | % |
| Other Components | $105.85 Million | % |
| Total Equity | $-13.18 Million | 100.00% |
Nanomix Corporation Competitors by Market Cap
The table below lists competitors of Nanomix Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Small Business Development Group Inc
PINK:SBDG
|
$4.67K |
|
BluSky AI, Inc.
PINK:IMIID
|
$4.68K |
|
I-Minerals Inc
PINK:IMAHF
|
$4.68K |
|
Affinity Gold Corp
PINK:AFYG
|
$4.68K |
|
BUA FOODS PLC
XNSA:BUAFOODS
|
$4.67K |
|
TXN
WAR:TXN
|
$4.67K |
|
Nishat Mills Ltd
KAR:NML
|
$4.67K |
|
Viet Brand Invest JSC
VN:ABR
|
$4.67K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Nanomix Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from -6,035,451 to -13,179,161, a change of -7,143,710.
- Net loss of 12,332,976 reduced equity.
- Dividend payments of 63,172 reduced retained earnings.
- Share repurchases of 4,610,000 reduced equity.
- New share issuances of 1,000,000 increased equity.
- Other comprehensive income increased equity by 217,625.
- Other factors increased equity by 8,644,813.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-12.33 Million | -93.58% |
| Dividends Paid | $63.17K | -0.48% |
| Share Repurchases | $4.61 Million | -34.98% |
| Share Issuances | $1.00 Million | +7.59% |
| Other Comprehensive Income | $217.62K | +1.65% |
| Other Changes | $8.64 Million | +65.59% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Nanomix Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2010-12-31 | $0.05 | $0.00 | x |
| 2011-12-31 | $0.03 | $0.00 | x |
| 2015-12-31 | $-2.35 | $0.00 | x |
| 2016-12-31 | $-12.39 | $0.00 | x |
| 2017-12-31 | $-13.05 | $0.00 | x |
| 2018-12-31 | $-7.00 | $0.00 | x |
| 2019-12-31 | $-10.27 | $0.00 | x |
| 2020-12-31 | $-2914.26 | $0.00 | x |
| 2021-12-31 | $-1.14 | $0.00 | x |
| 2022-12-31 | $-325.74 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Nanomix Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -79825.09%
- • Asset Turnover: 0.02x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-24.13%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2010 | -46.51% | -58012.85% | 0.00x | 1.84x | $-301.68K |
| 2011 | -194.77% | -20115.95% | 0.00x | 2.71x | $-869.64K |
| 2015 | 0.00% | -2516.46% | 0.11x | 0.00x | $-2.44 Million |
| 2016 | 0.00% | -3779.93% | 0.07x | 0.00x | $-3.43 Million |
| 2017 | 0.00% | -5398.80% | 0.03x | 0.00x | $-1.20 Million |
| 2018 | 0.00% | -11515.42% | 0.02x | 0.00x | $-3.19 Million |
| 2019 | 0.00% | -14521.26% | 0.69x | 0.00x | $-1.71 Million |
| 2020 | 0.00% | -12386.56% | 0.11x | 0.00x | $-6.23 Million |
| 2021 | 0.00% | -8239.79% | 0.16x | 0.00x | $-11.08 Million |
| 2022 | 0.00% | -79825.09% | 0.02x | 0.00x | $-11.02 Million |
Industry Comparison
This section compares Nanomix Corporation's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Nanomix Corporation (NNMX) | $-13.83 Million | -46.51% | N/A | $4.67K |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |